{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:46:16Z","timestamp":1791391576265,"version":"4.3.3"},"reference-count":115,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Accumulating evidence indicates that the pathological changes of the endothelium may contribute to the development of cardiovascular complications in chronic kidney disease (CKD). Non-traditional risk factors related to CKD are associated with the incidence of cardiovascular disease, but their role in uraemic endothelial dysfunction has often been disregarded. In this context, soluble \u03b1-Klotho and vitamin D are of importance to maintain endothelial integrity, but their concentrations decline in CKD, thereby contributing to the dysfunction of the endothelial lining. These hormonal disturbances are accompanied by an increment of circulating fibroblast growth factor-23 and phosphate, both exacerbating endothelial toxicities. Furthermore, impaired renal function leads to an increment of inflammatory mediators, reactive oxygen species and uraemic toxins that further aggravate the endothelial abnormalities and in turn also inhibit the regeneration of disrupted endothelial lining. Here, we highlight the distinct endothelial alterations mediated by the abovementioned non-traditional risk factors as demonstrated in experimental studies and connect these to pathological changes in CKD patients, which are driven by endothelial disturbances, other than atherosclerosis. In addition, we describe therapeutic strategies that may promote restoration of endothelial abnormalities by modulating imbalanced mineral homoeostasis and attenuate the impact of uraemic retention molecules, inflammatory mediators and reactive oxygen species. A clinical perspective on endothelial dysfunction in CKD may translate into reduced structural and functional abnormalities of the vessel wall in CKD, and ultimately improved cardiovascular disease.<\/jats:p>","DOI":"10.1093\/ndt\/gfz055","type":"journal-article","created":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T20:09:47Z","timestamp":1551557387000},"page":"1478-1487","source":"Crossref","is-referenced-by-count":53,"title":["Most exposed: the endothelium in chronic kidney disease"],"prefix":"10.1093","volume":"35","author":[{"given":"Marc","family":"Vila Cuenca","sequence":"first","affiliation":[{"name":"Department of Nephrology, Amsterdam Cardiovascular Sciences, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L","family":"Hordijk","sequence":"additional","affiliation":[{"name":"Department of Physiology, Amsterdam Cardiovascular Sciences, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4607-9415","authenticated-orcid":false,"given":"Marc G","family":"Vervloet","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Amsterdam Cardiovascular Sciences, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"key":"2021020415152420900_gfz055-B1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/kisup.2011.6","article-title":"The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda","volume":"1","author":"Fliser","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"2021020415152420900_gfz055-B2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2215\/CJN.07870713","article-title":"Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4","volume":"9","author":"Seiler","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B3","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ Res"},{"key":"2021020415152420900_gfz055-B4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijcard.2017.10.122","article-title":"Chronic kidney disease is associated with vascular smooth muscle dysfunction but not with endothelial dysfunction","volume":"254","author":"Iwamoto","year":"2018","journal-title":"Int J Cardiol"},{"key":"2021020415152420900_gfz055-B5","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","article-title":"Endothelial dysfunction","volume":"15","author":"Endemann","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B6","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1093\/ndt\/gfr081","article-title":"Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes","volume":"26","author":"Yilmaz","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"2021020415152420900_gfz055-B7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.atherosclerosis.2011.02.017","article-title":"Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease\u2013a cross-sectional study of predialysis, dialysis and kidney-transplantation patients","volume":"216","author":"Recio-Mayoral","year":"2011","journal-title":"Atherosclerosis"},{"key":"2021020415152420900_gfz055-B8","doi-asserted-by":"crossref","first-page":"e0138461","DOI":"10.1371\/journal.pone.0138461","article-title":"Inflammation, endothelial dysfunction and increased left ventricular mass in chronic kidney disease (CKD) patients: a longitudinal study","volume":"10","author":"Ioannou","year":"2015","journal-title":"PLoS One"},{"key":"2021020415152420900_gfz055-B9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2005080834","article-title":"Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study","volume":"17","author":"Stam","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B10","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2215\/CJN.01260211","article-title":"Flow-mediated vasodilation in end-stage renal disease","volume":"6","author":"Verbeke","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1046\/j.1523-1755.2001.0600031077.x","article-title":"Impaired endothelial function in isolated human uremic resistance arteries","volume":"60","author":"Morris","year":"2001","journal-title":"Kidney Int"},{"key":"2021020415152420900_gfz055-B12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.ajkd.2005.09.029","article-title":"The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine","volume":"47","author":"Yilmaz","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2021020415152420900_gfz055-B13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00004872-200103001-00005","article-title":"Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension","volume":"19","author":"Ghiadoni","year":"2001","journal-title":"J Hypertens"},{"key":"2021020415152420900_gfz055-B14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/157016112798829760","article-title":"The role of nitric oxide on endothelial function","volume":"10","author":"Tousoulis","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"2021020415152420900_gfz055-B15","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00424.2007","article-title":"Nitric oxide deficiency in chronic kidney disease","volume":"294","author":"Baylis","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"2021020415152420900_gfz055-B16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","article-title":"Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease","volume":"65","author":"Oberg","year":"2004","journal-title":"Kidney Int"},{"key":"2021020415152420900_gfz055-B17","doi-asserted-by":"crossref","first-page":"e00145","DOI":"10.1002\/phy2.145","article-title":"Differential regulation of nitric oxide synthase function in aorta and tail artery from 5\/6 nephrectomized rats","volume":"1","author":"Spradley","year":"2013","journal-title":"Physiol Rep"},{"key":"2021020415152420900_gfz055-B18","doi-asserted-by":"crossref","first-page":"625852","DOI":"10.1155\/2010\/625852","article-title":"Vitamin d receptor activation mitigates the impact of uremia on endothelial function in the 5\/6 nephrectomized rats","volume":"2010","author":"Wu-Wong","year":"2010","journal-title":"Int J Endocrinol"},{"key":"2021020415152420900_gfz055-B19","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/ndt\/gfg080","article-title":"Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity","volume":"18","author":"Stam","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"2021020415152420900_gfz055-B20","doi-asserted-by":"crossref","first-page":"e0132047","DOI":"10.1371\/journal.pone.0132047","article-title":"Interrelationship of multiple endothelial dysfunction biomarkers with chronic kidney disease","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"2021020415152420900_gfz055-B21","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1681\/ASN.2005050535","article-title":"Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure","volume":"16","author":"Amabile","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B22","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0272-6386(03)00906-5","article-title":"Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients","volume":"42","author":"Ko\u00e7","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2021020415152420900_gfz055-B23","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/ndt\/gfp749","article-title":"Progenitor cells and vascular function are impaired in patients with chronic kidney disease","volume":"25","author":"Jie","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2021020415152420900_gfz055-B24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10157-012-0664-9","article-title":"Value and level of circulating endothelial progenitor cells, angiogenesis factors and mononuclear cell apoptosis in patients with chronic kidney disease","volume":"17","author":"Chen","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"2021020415152420900_gfz055-B25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000245643","article-title":"Endothelial progenitor cells and endothelial vesicles - what is the significance for patients with chronic kidney disease?","volume":"29","author":"Mohandas","year":"2010","journal-title":"Blood Purif"},{"key":"2021020415152420900_gfz055-B26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/ndt\/gfg161","article-title":"Uraemic medium accelerates proliferation but does not induce apoptosis of endothelial cells in culture","volume":"18","author":"Serradell","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"2021020415152420900_gfz055-B27","first-page":"1053","article-title":"Uremic medium causes expression, redistribution and shedding of adhesion molecules in cultured endothelial cells","volume":"87","author":"Serradell","year":"2002","journal-title":"Haematologica"},{"key":"2021020415152420900_gfz055-B28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1053\/j.ajkd.2007.11.029","article-title":"Differential expression of proteins from cultured endothelial cells exposed to uremic versus normal serum","volume":"51","author":"Carb\u00f3","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"2021020415152420900_gfz055-B29","doi-asserted-by":"crossref","first-page":"e30975","DOI":"10.1371\/journal.pone.0030975","article-title":"Hemodialysis removes uremic toxins that alter the biological actions of endothelial cells","volume":"7","author":"Zafeiropoulou","year":"2012","journal-title":"PLoS One"},{"key":"2021020415152420900_gfz055-B30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/ndt\/gfy111","article-title":"Stabilization of cell-cell junctions by active vitamin D ameliorates uraemia-induced loss of human endothelial barrier function","volume":"34","author":"Vila Cuenca","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2021020415152420900_gfz055-B31","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3390\/toxins10100404","article-title":"Uremia impacts VE-cadherin and ZO-1 expression in human endothelial cell-to-cell junctions","volume":"10","author":"Maciel","year":"2018","journal-title":"Toxins"},{"key":"2021020415152420900_gfz055-B32","doi-asserted-by":"crossref","first-page":"e008776","DOI":"10.1161\/JAHA.118.008776","article-title":"Vitamin D attenuates endothelial dysfunction in uremic rats and maintains human endothelial stability","volume":"7","author":"Vila Cuenca","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2021020415152420900_gfz055-B33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse Klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-O","year":"1997","journal-title":"Nature"},{"key":"2021020415152420900_gfz055-B34","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/01.CIR.0000139854.74847.99","article-title":"Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse","volume":"110","author":"Shimada","year":"2004","journal-title":"Circulation"},{"key":"2021020415152420900_gfz055-B35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1006\/bbrc.1999.2009","article-title":"Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys","volume":"267","author":"Kato","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"2021020415152420900_gfz055-B36","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1016\/j.febslet.2009.09.009","article-title":"Klotho is a substrate for alpha-, beta- and gamma-secretase","volume":"583","author":"Bloch","year":"2009","journal-title":"FEBS Lett"},{"key":"2021020415152420900_gfz055-B37","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/bbrc.1998.8943","article-title":"Klotho protein protects against endothelial dysfunction","volume":"248","author":"Saito","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2021020415152420900_gfz055-B38","doi-asserted-by":"crossref","first-page":"e93423","DOI":"10.1371\/journal.pone.0093423","article-title":"Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium","volume":"9","author":"Six","year":"2014","journal-title":"PLoS One"},{"key":"2021020415152420900_gfz055-B39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s12020-009-9181-3","article-title":"Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation","volume":"35","author":"Maekawa","year":"2009","journal-title":"Endocrine"},{"key":"2021020415152420900_gfz055-B40","doi-asserted-by":"crossref","first-page":"19308","DOI":"10.1073\/pnas.1008544107","article-title":"Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity","volume":"107","author":"Kusaba","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021020415152420900_gfz055-B41","doi-asserted-by":"crossref","first-page":"e56695","DOI":"10.1371\/journal.pone.0056695","article-title":"A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease","volume":"8","author":"Kitagawa","year":"2013","journal-title":"PLoS One"},{"key":"2021020415152420900_gfz055-B42","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.transproceed.2014.09.015","article-title":"FGF23 and Klotho in relation to markers of endothelial dysfunction in kidney transplant recipients","volume":"46","author":"Malyszko","year":"2014","journal-title":"Transplant Proc"},{"key":"2021020415152420900_gfz055-B43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1620\/tjem.237.17","article-title":"Low serum level of Klotho is an early predictor of atherosclerosis","volume":"237","author":"Keles","year":"2015","journal-title":"Tohoku J Exp Med"},{"key":"2021020415152420900_gfz055-B44","first-page":"S5","article-title":"Vitamin D and chronic kidney disease","volume":"19","author":"Williams","year":"2009","journal-title":"Ethn Dis"},{"key":"2021020415152420900_gfz055-B45","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/ndt\/gfy122","article-title":"Vitamin D deficiency is associated with mortality in maintenance dialysis: moving forward from epidemiology to clinical trials","volume":"33","author":"Bacchetta","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2021020415152420900_gfz055-B46","doi-asserted-by":"crossref","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","article-title":"Vitamin D","volume":"289","author":"Dusso","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"2021020415152420900_gfz055-B47","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1681\/ASN.2006060573","article-title":"Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency","volume":"18","author":"London","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2011.10.023","article-title":"Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients","volume":"220","author":"Chitalia","year":"2012","journal-title":"Atherosclerosis"},{"key":"2021020415152420900_gfz055-B49","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000348755","article-title":"Two novel vitamin D receptor modulators with similar structures exhibit different hypercalcemic effects in 5\/6 nephrectomized uremic rats","volume":"37","author":"Wu-Wong","year":"2013","journal-title":"Am J Nephrol"},{"key":"2021020415152420900_gfz055-B50","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/HYPERTENSIONAHA.114.03748","article-title":"Paricalcitol and endothelial function in chronic kidney disease trial","volume":"64","author":"Zoccali","year":"2014","journal-title":"Hypertension"},{"key":"2021020415152420900_gfz055-B51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/hdi.12439","article-title":"Effect of vitamin D supplementation on endothelial dysfunction in hemodialysis patients","volume":"21","author":"Karakas","year":"2017","journal-title":"Hemodial Int"},{"key":"2021020415152420900_gfz055-B52","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2215\/CJN.10791016","article-title":"Randomized controlled trial for the effect of vitamin D supplementation on vascular stiffness in CKD","volume":"12","author":"Levin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B53","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1681\/ASN.2017010003","article-title":"A randomized trial of vitamin D supplementation on vascular function in CKD","volume":"28","author":"Kumar","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B54","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1210\/jc.2008-1212","article-title":"Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects","volume":"94","author":"Tarcin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2021020415152420900_gfz055-B55","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/1358863X12466709","article-title":"The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease","volume":"17","author":"Sokol","year":"2012","journal-title":"Vasc Med"},{"key":"2021020415152420900_gfz055-B56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1464-5491.2007.02360.x","article-title":"Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels","volume":"25","author":"Sugden","year":"2008","journal-title":"Diabet Med"},{"key":"2021020415152420900_gfz055-B57","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2215\/CJN.01870217","article-title":"Cholecalciferol, calcitriol, and vascular function in CKD: a randomized, double-blind trial","volume":"12","author":"Kendrick","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD\u2013the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"key":"2021020415152420900_gfz055-B60","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1001\/jama.2018.17749","article-title":"Effect of oral alfacalcidol on clinical outcomes in patients without secondary hyperparathyroidism receiving maintenance hemodialysis: The J-DAVID randomized clinical trial","volume":"320","author":"Shoji","year":"2018","journal-title":"JAMA"},{"key":"2021020415152420900_gfz055-B61","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int"},{"key":"2021020415152420900_gfz055-B62","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"2021020415152420900_gfz055-B63","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B64","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ki.2012.416","article-title":"\u2018Shedding\u2019 light on mechanisms of hyperphosphatemic vascular dysfunction","volume":"83","author":"Burger","year":"2013","journal-title":"Kidney Int"},{"key":"2021020415152420900_gfz055-B65","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1681\/ASN.2008101106","article-title":"Dietary phosphorus acutely impairs endothelial function","volume":"20","author":"Shuto","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ki.2012.300","article-title":"High phosphate directly affects endothelial function by downregulating annexin II","volume":"83","author":"Di Marco","year":"2013","journal-title":"Kidney Int"},{"key":"2021020415152420900_gfz055-B67","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1681\/ASN.2014070642","article-title":"Hyperphosphatemia, phosphoprotein phosphatases, and microparticle release in vascular endothelial cells","volume":"26","author":"Abbasian","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B68","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/cvr\/cvs240","article-title":"Effects of phosphate on vascular function under normal conditions and influence of the uraemic state","volume":"96","author":"Six","year":"2012","journal-title":"Cardiovasc Res"},{"key":"2021020415152420900_gfz055-B69","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11154-011-9199-8","article-title":"The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis","volume":"13","author":"Haussler","year":"2012","journal-title":"Rev Endocr Metab Disord"},{"key":"2021020415152420900_gfz055-B70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","article-title":"Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community","volume":"205","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"2021020415152420900_gfz055-B71","doi-asserted-by":"crossref","first-page":"H1414","DOI":"10.1152\/ajpheart.00272.2018","article-title":"FGF23 impairs peripheral microvascular function in renal failure","volume":"315","author":"Verkaik","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2021020415152420900_gfz055-B72","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","article-title":"FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability","volume":"307","author":"Silswal","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2021020415152420900_gfz055-B73","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int"},{"key":"2021020415152420900_gfz055-B74","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1525-139X.2011.00925.x","article-title":"Vascular incompetence in dialysis patients\u2013protein-bound uremic toxins and endothelial dysfunction","volume":"24","author":"Jourde-Chiche","year":"2011","journal-title":"Semin Dial"},{"key":"2021020415152420900_gfz055-B75","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"2021020415152420900_gfz055-B76","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia","volume":"98","author":"B\u00f6ger","year":"1998","journal-title":"Circulation"},{"key":"2021020415152420900_gfz055-B77","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/ki.2011.476","article-title":"Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine","volume":"81","author":"Kajimoto","year":"2012","journal-title":"Kidney Int"},{"key":"2021020415152420900_gfz055-B78","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1242\/jcs.002212","article-title":"The ADMA\/DDAH pathway is a critical regulator of endothelial cell motility","volume":"120","author":"Wojciak-Stothard","year":"2007","journal-title":"J Cell Sci"},{"key":"2021020415152420900_gfz055-B79","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jacc.2005.04.066","article-title":"Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine","volume":"46","author":"Thum","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2021020415152420900_gfz055-B80","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1681\/ASN.2014101047","article-title":"Uremic toxicity of advanced glycation end products in CKD","volume":"27","author":"Stinghen","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B81","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.ASN.0000065100.17349.CA","article-title":"Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy","volume":"14","author":"Wendt","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B82","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1523-1755.2004.00860.x","article-title":"Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells","volume":"66","author":"Rashid","year":"2004","journal-title":"Kidney Int"},{"key":"2021020415152420900_gfz055-B83","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2215\/CJN.04291007","article-title":"Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation","volume":"3","author":"Linden","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B84","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ki.2008.31","article-title":"Free p-cresol is associated with cardiovascular disease in hemodialysis patients","volume":"73","author":"Meijers","year":"2008","journal-title":"Kidney Int"},{"key":"2021020415152420900_gfz055-B85","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.ajkd.2009.04.022","article-title":"The uremic retention solute p-cresyl sulfate and markers of endothelial damage","volume":"54","author":"Meijers","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"2021020415152420900_gfz055-B86","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1160\/TH03-07-0491","article-title":"P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro","volume":"92","author":"Cerini","year":"2004","journal-title":"Thromb Haemost"},{"key":"2021020415152420900_gfz055-B87","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B88","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1159\/000452604","article-title":"Indoxyl sulfate impairs endothelial progenitor cells and might contribute to vascular dysfunction in patients with chronic kidney disease","volume":"41","author":"Lin","year":"2016","journal-title":"Kidney Blood Press Res"},{"key":"2021020415152420900_gfz055-B89","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1538-7836.2005.01780.x","article-title":"Elevation of circulating endothelial microparticles in patients with chronic renal failure","volume":"4","author":"Faure","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2021020415152420900_gfz055-B90","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1523-1755.2004.00399.x","article-title":"The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair","volume":"65","author":"Dou","year":"2004","journal-title":"Kidney Int"},{"key":"2021020415152420900_gfz055-B91","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/jcb.23435","article-title":"Effects of indoxyl sulfate on adherens junctions of endothelial cells and the underlying signaling mechanism","volume":"113","author":"Peng","year":"2012","journal-title":"J Cell Biochem"},{"key":"2021020415152420900_gfz055-B92","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/ndt\/16.11.2240","article-title":"Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis","volume":"16","author":"Chung","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"2021020415152420900_gfz055-B93","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.ajkd.2006.08.015","article-title":"Oxidative stress is progressively enhanced with advancing stages of CKD","volume":"48","author":"Dounousi","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2021020415152420900_gfz055-B94","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000085686","article-title":"Oxidative stress and reactive oxygen species","volume":"149","author":"Galli","year":"2005","journal-title":"Contrib Nephrol"},{"key":"2021020415152420900_gfz055-B95","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cvsm.2007.11.001","article-title":"Oxidative stress and chronic kidney disease","volume":"38","author":"Brown","year":"2008","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"2021020415152420900_gfz055-B96","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1046\/j.1523-1755.2002.00166.x","article-title":"Endothelial dysfunction and hypertension in 5\/6 nephrectomized rats are mediated by vascular superoxide","volume":"61","author":"Hasdan","year":"2002","journal-title":"Kidney Int"},{"key":"2021020415152420900_gfz055-B97","first-page":"381","article-title":"Oxidative stress and endothelial dysfunction in chronic kidney disease","volume":"92","author":"Costa-Hong","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"2021020415152420900_gfz055-B98","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1096\/fasebj.13.10.1137","article-title":"Is NF-kappaB the sensor of oxidative stress?","volume":"13","author":"Li","year":"1999","journal-title":"FASEB J"},{"key":"2021020415152420900_gfz055-B99","doi-asserted-by":"crossref","first-page":"678","DOI":"10.18632\/aging.100080","article-title":"Role of NFkappaB in age-related vascular endothelial dysfunction in humans","volume":"1","author":"Donato","year":"2009","journal-title":"Aging (Albany NY)"},{"key":"2021020415152420900_gfz055-B100","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.ajkd.2003.10.037","article-title":"Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study","volume":"43","author":"Landray","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2021020415152420900_gfz055-B101","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.kint.2016.10.034","article-title":"Recombinant \u03b1-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy","volume":"91","author":"Hu","year":"2017","journal-title":"Kidney Int"},{"key":"2021020415152420900_gfz055-B102","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1681\/ASN.2015060613","article-title":"\u03b1Klotho mitigates progression of AKI to CKD through activation of autophagy","volume":"27","author":"Shi","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2021020415152420900_gfz055-B103","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/gerona\/glu170","article-title":"Klotho prevents NF\u03baB translocation and protects endothelial cell from senescence induced by uremia","volume":"70","author":"Buend\u00eda","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2021020415152420900_gfz055-B104","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.toxlet.2012.10.004","article-title":"Amelioration of uremic toxin indoxyl sulfate-induced endothelial cell dysfunction by Klotho protein","volume":"215","author":"Yang","year":"2012","journal-title":"Toxicol Lett"},{"key":"2021020415152420900_gfz055-B105","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00424-016-1858-x","article-title":"Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells","volume":"468","author":"Richter","year":"2016","journal-title":"Pflugers Arch"},{"key":"2021020415152420900_gfz055-B106","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jdiacomp.2015.01.004","article-title":"Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease","volume":"29","author":"Thethi","year":"2015","journal-title":"J Diabetes Complications"},{"key":"2021020415152420900_gfz055-B107","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1053\/j.ajkd.2011.11.007","article-title":"Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: a randomized clinical trial","volume":"59","author":"Yilmaz","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"2021020415152420900_gfz055-B108","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/ckj\/sfx074","article-title":"Sevelamer reduces endothelial inflammatory response to advanced glycation end products","volume":"11","author":"Gregorio","year":"2018","journal-title":"Clin Kidney J"},{"key":"2021020415152420900_gfz055-B109","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"2021020415152420900_gfz055-B110","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/08860220802272589","article-title":"Reduction of pro-inflammatory cytokines through hemodiafiltration","volume":"30","author":"Kuo","year":"2008","journal-title":"Ren Fail"},{"key":"2021020415152420900_gfz055-B111","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1046\/j.1523-1755.2000.07606.x","article-title":"The removal of uremic toxins","volume":"76","author":"Dhondt","year":"2000","journal-title":"Kidney Int Suppl"},{"key":"2021020415152420900_gfz055-B112","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.atherosclerosis.2015.09.019","article-title":"Deleterious vascular effects of indoxyl sulfate and reversal by oral adsorbent AST-120","volume":"243","author":"Six","year":"2015","journal-title":"Atherosclerosis"},{"key":"2021020415152420900_gfz055-B113","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3349\/ymj.2016.57.4.942","article-title":"AST-120 improves microvascular endothelial dysfunction in end-stage renal disease patients receiving hemodialysis","volume":"57","author":"Ryu","year":"2016","journal-title":"Yonsei Med J"},{"key":"2021020415152420900_gfz055-B114","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1111\/j.1600-6143.2006.01555.x","article-title":"Kidney transplantation substantially improves endothelial progenitor cell dysfunction in patients with end-stage renal disease","volume":"6","author":"Herbrig","year":"2006","journal-title":"Am J Transplant"},{"key":"2021020415152420900_gfz055-B115","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/01.TP.0000086343.32903.A8","article-title":"Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients","volume":"76","author":"Covic","year":"2003","journal-title":"Transplantation"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/35\/9\/1478\/36195072\/gfz055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/35\/9\/1478\/36195072\/gfz055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T12:01:26Z","timestamp":1612785686000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/35\/9\/1478\/5432726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":115,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,4,8]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfz055","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9,1]]},"published":{"date-parts":[[2019,4,8]]}}}